FeLV, a retrovirus, is the most important infectious disease agent producing fatal illness
in domestic cats today.
The feline leukemia virus is excreted in saliva and tears and possibly the urine and feces of infected cats. Prolonged, extensive cat-to-cat contact is required for efficient spread, because the virus is rapidly inactivated by warmth and drying.
A cat with FeLV disease may live for several weeks to several months, depending on how advanced the disease is at the time of diagnosis. However, it is impossible to tell how long any particular cat will survive.
A significant percentage of adult cats that are exposed to the virus develop immunity and do not become persistently viremic (i.e., will not carry the virus indefinitely in the blood and bone marrow).
Usually those cats live out a normal life span. However, in some the virus may remain sequestered for a variable period of time somewhere in the body. It is thus conceivable that FeLV might break out and cause disease at a later date, after the cats have been stressed, or perhaps medicated with drugs that suppress the immune system.
Although the possibility that FeLV can be transmitted to human beings and cause disease cannot be ruled out completely, there certainly is no evidence to date that transmission does occur, despite decades of extensive research. Also, there is no known association of FeLV with acquired immune deficiency syndrome (AIDS) in human beings. It is true that FeLV can be grown in human cells in culture; the same is true of other infectious disease agents that nevertheless do not produce disease in human beings. Similarly there is no evidence that FeLV is carried by, or causes any illness, in dogs.
Common clinical signs produced by FeLV include anemia, jaundice, depression, weight loss, decreased appetite, diarrhea or constipation, blood in the stool, enlarged lymph nodes, respiratory distress, decreased stamina, excessive drinking and urination, fetal resorption, abortion, infertility, birth of “fading” kittens, and a syndrome resembling panleukopenia (“cat distemper”). FeLV also interferes with the cat’s natural ability to ward off infectious disease agents, so that almost any severe, chronic illness may lead your veterinarian to suspect FeLV.
Cancer occurs in some FeLV-infected cats. In those cats the tumor masses may cause such problems as respiratory distress; intestinal inflammation with diarrhea, vomiting or constipation; liver or kidney disease; cloudy eyes; and neurologic abnormalities.
Even if two or more successive tests reveal your cat to be truly positive, it will not necessarily die. An FeLV-positive healthy cat may live for months or years; the life expectancy is impossible to predict. Your cat is probably shedding virus that could infect other cats, however, and you should take precautions to reduce the chance of spreading the disease. In addition, the body’s reaction to the virus may protect it from the primary FeLV disease problems but not from the immune-system suppression that the virus also can cause. Your cat thus may be much more susceptible to other infectious diseases and will require careful monitoring and immediate treatment should illness become apparent.
To date there is no cure for FeLV infection or disease. A variety of chemotherapeutic regimens have been developed, and in certain cases those regimens can produce a temporary remission, depending on the physical condition of the cat and the type of disease that is present. Those drug therapies may allow the cat to continue in a reasonably healthy state for a period of several weeks to several months. However, it must be understood that those are only remissions and not permanent cures. Chemotherapeutic drugs are very potent, and their effects must be monitored carefully, to avoid overdosing the patient.
Various antiviral compounds including interferon may also be used to treat cats with FeLV infection. Those compounds, while still experimental, are generally safer to use than chemotherapeutic agents, and may reduce the amount of virus present in the blood of the cat, and may extend the period of remission of clinical disease. As yet, antiviral compounds do not produce permanent cures for FeLV infection or disease. Hopefully, additional research will produce effective antiviral therapies that will cure FeLV disease.
There is no scientific documentation that vitamin C cures cats of leukemia. Controlled studies of feline viral rhinotracheitis, canine distemper, and human respiratory infections have failed to show effectiveness of high doses of vitamin C. Of course, a multivitamin and mineral supplement may be helpful to any sick animal that is not eating properly; however, there is little evidence to support claims that such a supplement can cure any of those conditions. Other than providing general support to the animal’s health, vitamin and mineral supplements, in our estimation, are not effective in preventing the spread of FeLV within a cattery and certainly will not cure an individual cat of its infection.
Therapy with a steroid (such as prednisolone) acts to decrease the numbers of some circulating white blood cells (lymphocytes). A cat with leukemia may have an increased number of abnormal (cancerous) lymphocytes circulating in its bloodstream; therefore steroid treatment may help to destroy them. Prednisolone may also act directly against the cells of some solid tumors (such as lymphosarcoma) that are caused by FeLV. Steroids also inhibit the cells that are normally responsible for destroying senescent red blood cells; that effect may help to combat the anemia and excessive red blood cell destruction that often accompany FeLV.
It is important to remember that because steroids and FeLV both suppress the immune system, an FeLV-positive cat undergoing steroid therapy is especially vulnerable to other infections.
Several vaccines are now available to aid in the protection of your cat against FeLV infection. The vaccines are produced by various methods, and either contain the inactivated (“killed”) whole virus, or a subunit protein of the virus. The principle of protection is the same for each of these vaccines.
The FeLV vaccines are as safe as other commonly used feline vaccines. As with any vaccine in animals or humans, some reaction to the vaccine may occur in a relatively small number of vaccinations. The vast majority of cats vaccinated with FeLV vaccines will experience no reaction at all. Occasionally, your cat will experience some malaise for a few hours or for a day or two after vaccination. On rare occasions, an allergic reaction to one of the components of the vaccine may occur which will result in fever, diarrhea, and malaise. This allergic reaction can be treated by your veterinarian.
The FeLV vaccines are reasonably effective in preventing persistent FeLV infection should your vaccinated cat be exposed to the virus. No vaccine is 100 percent effective, and this is true for the FeLV vaccines. The immune response produced by these vaccines will protect most exposed cats from becoming infected with the virus. Occasionally after exposure to the feline leukemia virus, a vaccinated cat will develop a transient viremia (temporarily become FeLV positive for up to 12 weeks), but the immune response produced by the vaccine will control the virus such that these cats will not develop clinical disease. Unfortunately, a small percentage of FeLV-vaccinated cats will not be protected against exposure to FeLV.
Kittens should be vaccinated twice starting at nine to ten weeks of age, with the second dose of the vaccine given three to four weeks later. Your cat should receive annual revaccinations (“booster” vaccinations) against FeLV.
The FeLV vaccines are not 100 percent effective, and thus a degree of risk occurs when a vaccinated cat is housed with a persistently-infected cat (FeLV-positive cat). It is recommended that FeLV-positive cats not be housed with FeLV-negative cats, even those that have been vaccinated. Certainly, a cat vaccinated against FeLV will have a far greater chance of successfully withstanding an exposure to FeLV than an unvaccinated cat.
No, vaccination will not interfere with either the ELISA or IFA diagnostic tests. The vaccines do not contain living virus, and the diagnostic tests detect a specific protein within the virus. Antibodies against FeLV, produced as a result of vaccination, are not detected by the diagnostic tests.
In either a cattery or a multicat household, the most effective procedure is to test by IFA and remove all FeLV-positive cats. The remaining FeLV-negative cats should then be vaccinated and retested every three to six months for the next year, and any that become positive during that time should be removed. The household cannot be considered “free” of FeLV until all remaining cats have tested negative in two sequential tests taken at least three months apart. No new cats should be brought into the household until all the cats already there test negative repeatedly. All new cats should test negative initially, be quarantined for at least two months, and retest negative before being allowed to mingle with other resident cats.
The premises should be routinely scrubbed with detergent or disinfectant and wiped down with a solution containing four ounces of household bleach per gallon of water (bleach is an excellent disinfectant for viruses and other infectious disease agents). All food and water bowls, bedding material, and litter pans should be thoroughly cleaned and disinfected. Better yet, they should be replaced.
Feline leukemia virus is relatively unstable and will not survive outside an infected cat for an appreciable length of time. The Cornell Feline Health Center recommends a waiting period of at least thirty days after removal of an FeLV-positive cat before a new cat is acquired. Other precautions that should be taken are identical to those described above to protect healthy cats. Thoroughly disinfect or replace the food dishes, litter pans, and bedding that were used by the infected cat. Floors that are covered with tile or other hard surfaces should be cleaned and then disinfected with dilute bleach solution (4 oz. household bleach to 1 gal. water). Thorough vacuuming of rugs, plus the thirty-day quarantine, should be sufficient to eliminate the virus from carpeting in the household.
Removal of persistently FeLV-positive (positive on the IFA test) cats from a household is the only proven effective method for FeLV control. The question naturally arises: what is to be done with such cats after their removal? In the past, some have recommended euthanasia (because there is no reliable means of eliminating the virus from the cat’s body, the cat itself must be destroyed, to destroy the virus). Euthanasia has also been put forth as the only effective means for preventing further spread of FeLV within the cat population at large. The question of euthanizing a positive cat is one that must be addressed in each individual case, in consultation with the attending veterinarian. Vaccination against FeLV does not completely replace testing and removal as the method of choice for controlling FeLV.
If you own only one cat and it is FeLV-positive, euthanasia is not necessary from the standpoint of controlling virus transmission, so long as you keep your cat indoors and away from all other cats. You must remember, however, that in time the cat may develop an FeLV-related illness and become so uncomfortable that euthanasia becomes the only humane course of action.
If you have only a few cats and are reluctant to have a positive one destroyed, particularly if it is clinically healthy, a strict intrahousehold quarantine program may permit you to protect your other cats from infection. The FeLV-positive cat must be prevented from having any contact with the negative cats, perhaps by housing it in a separate room within the house. Separate feeding utensils and litter pans should be provided, and hands should be thoroughly washed and clothing (including shoes) after handling and caring for the positive cat. The positive cat should never be allowed outdoors, where it might come into contact with FeLV-negative cats and transmit the virus.
Feline leukemia virus is transmitted from carrier queens to their kittens either in utero or after birth. A very high percentage of kittens born to infected queens will succumb to FeLV infection or FeLV-related disease. In our estimation it is absolutely essential that you establish a test-and-removal program, so that all persistently infected animals are removed from the cattery. Continuing to breed FeLV-positive queens merely expands the problem and in essence signs the death warrant of kittens born to those queens.
Our research on FeLV has involved basic studies of the virus itself; attempts to develop more effective vaccines; and evaluations of the effectiveness of current FeLV vaccines, therapies, and diagnostic tests. Our efforts are directed toward eliminating forever the threat of this devastating viral infection.
Article courtesy of the Cornell Feline Health Center, Cornell University, College of Veterinary Medicine, Ithaca, New York 14853-6401
Included with this article, courtesy of Steven Slagle, DVM, is his testimonial on the effectiveness of Transfer Factor in his veterinary practice, and how a cat with feline leukemia fully recovered:
“Transfer factors and transfer factor Plus have turned out to be the most effective and versatile products I have ever used in my 32-year veterinary practice.
Here are a few examples:
A cat with leukemia, an oral tumor, and posterior paralysis due to a spinal tumor, was very ill and emaciated. One month after enhanced transfer factors (1 cap daily), there was some regression of the oral tumor, restored appetite with some weight gain, and increased sociability. Five months later, she continues to improve, regaining normal weight, 80% regression of her oral tumor, and regaining use of hind legs and tail.
Victor, a 10-year-old gelding, with EPM was treated with conventional drug therapy for 5 weeks and yet continued to deteriorate. At week 6, I started him on enhanced transfer factors (6 caps/day). Within one week, he showed noticeable improvement, and within 30 days, he was able to show. Since his full recovery 4 months ago, Victor has continued to show at his original performance level.”
Dr. Slagle says that he has used these products as stand-alone and in conjunction with allopathic therapies in the following cases with excellent results:
CANCER: Canine lipomas, Canine/feline hepatic tumors, Equine squamous cell carcinoma, Equine melanomas; Feline leukemia, oral tumors. VIRAL/BACTERIAL: Upper and lower respiratory infections, Canine/feline dermatoses, Equine/bovine scours, Equine septic arthritis, Feline abscesses.
Transfer Factor is not intended to cure or treat disease. It is designed to enhance immune system function to optimal levels. The immune system enhancement is responsible for any clinical improvements.